The study randomly selected systemic lupus erythematosus patients currently experiencing cutaneous lupus erythematosus flares to treat their skin lesions with mupirocin or with an inactive control ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback